---
title: Ewing's Sarcoma
markmap:
  colorFreezeLevel: 3
---

# Ewing's Sarcoma

## Definition
- Highly malignant bone tumor
- Part of Ewing Sarcoma Family of Tumors (ESFT)
- Origin: Likely neural/mesenchymal stem cell

## Epidemiology
- Second most common primary bone tumor in children/young adults
- Peak incidence: 10-20 years
- Rare in <5 or >30

## Pathology
- Gross: Soft, gray-tan, necrotic, hemorrhagic
- Microscopy: Small, round, blue cell tumor
  - Uniform cells, scant cytoplasm
  - Glycogen rich (PAS positive)
  - Homer Wright rosettes (rare)
  - CD99 positive (Michelin tire appearance)

## Genetics
- Hallmark: Translocation t(11;22)(q24;q12)
  - Fusion gene: EWSR1-FLI1
- Other translocations: t(21;22) EWSR1-ERG, t(7;22) EWSR1-ETV1, etc.
- Immunohistochemistry: EWSR1 antibody

## Clinical Features
- Pain (most common symptom)
- Swelling
- Mass
- Systemic symptoms: Fever, weight loss, fatigue (mimics infection)
- Site: Diaphysis of long bones (femur, tibia, humerus)
  - Also pelvis, ribs, spine, scapula
- Pathological fracture (less common than OS)

## Imaging
- X-ray:
  - Ill-defined destructive lesion
  - Diaphyseal location
  - Periosteal reaction: Onion-skinning (laminated), Codman's triangle
  - Soft tissue mass
- MRI:
  - Best for local extent, marrow involvement, soft tissue mass
  - T1: Low signal
  - T2/STIR: High signal
- CT:
  - Bone detail, cortical destruction
- PET/CT:
  - Staging, follow-up
- Bone Scan:
  - Detects bone metastases

## Differential Diagnosis
- Osteomyelitis
- Eosinophilic granuloma
- Lymphoma of bone
- Neuroblastoma (metastatic)
- Other small round blue cell tumors

## Staging
- AJCC staging (Tumor size, Nodal involvement, Metastasis)
- Metastases: Lungs (most common), bone, bone marrow
- Work-up: Bone scan, CT chest/abdomen/pelvis, Bone marrow biopsy

## Treatment
- Multimodal approach
- Chemotherapy: Standard of care (Neoadjuvant and Adjuvant)
  - Vincristine, Adriamycin (Doxorubicin), Cyclophosphamide (VDC) + Ifosfamide, Etoposide (IE)
- Local control:
  - Surgery: Wide excision (preferred)
  - Radiation therapy: For unresectable tumors, positive margins, or unfavorable sites (pelvis, spine)
- Stem cell transplant (for high-risk or relapsed disease)

## Prognosis
- Dependent on:
  - Presence of metastasis (major prognostic factor)
  - Tumor size
  - Site (pelvis/spine worse)
  - Response to chemotherapy
- 5-year survival:
  - Localized disease: ~70-80%
  - Metastatic disease: ~20-30%

## INICET Buzzwords
- Small Round Blue Cell Tumor
- t(11;22)
- EWSR1-FLI1
- CD99 Positive
- Onion-skinning
- Diaphysis
- Chemosensitive
- VDC/IE regimen
- Pelvic Ewing's (Poor Prognosis)
- Metastases (Lung, Bone, Marrow)


